IL1B and Parkinson disease: In parallel, resveratrol markedly reduces neuroinflammation in toxin models: studies report that resveratrol-treated PD model animals have lower levels of pro-inflammatory mediators such as COX-2, TNF-α, and IL-1β in the nigrostriatal system, as well as reduced ROS accumulation (47).